COVID Vaccine Market Size, Share & Trends Analysis Report By Technology (Live Attenuated vaccines, Recombinant vaccines, Toxoid vaccines, Conjugate vaccines, Inactivated & Subunit vaccines, Viral vector vaccines), By Technology (mRNA vaccines, Viral Vector vaccines, Other vaccines (inactivated, recombinant, conjugate, subunit, peptide, and DNA vaccines), By Type (Monovalent vaccines, Multivalent vaccines), By Disease Indication (Meningococcal diseases,Rotavirus, MMR, Varicella, Influenza, Pneumococcal diseases, Combination vaccines, HPV, Herpes Zoster, Hepatitis, DTP, Polio, COVID 19, Other disease indications (cancer, dengue, tuberculosis, typhoid, Japanese encephalitis, rabies, yellow fever, and allergies)), By Route of Administration (Intramuscular & Subcutaneous administration, Oral administration, Other routes of administration (intranasal, intradermal, and percutaneous)), By End-user (Pediatric vaccines, Adult vaccines), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

Report ID: IMIR 004001 | Jul 2022 | Format:

Report Description

Table Of Contents

Research Methodology

Table of Content

Chapter 1 Global COVID Vaccine Market: Summary and Quantitative Analysis

1.1 Report Description
1.2 Global COVID Vaccine Market Revenue Overview
1.3 Global COVID Vaccine Market Revenue (USD Billion) and Growth (%) Rate, 2021- 2028

Chapter 2 Global COVID Vaccine Market: Overview and Qualitative Analysis

2.1 Executive Summary
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global COVID Vaccine Market: SWOT Analysis
2.7 Global COVID Vaccine Market: PEST Analysis
2.8 Global COVID Vaccine Market: Attractiveness Analysis
2.8.1 Global COVID Vaccine Market: Attractiveness Analysis by Type
2.8.2 Global COVID Vaccine Market: Attractiveness Analysis by Application
2.8.3 Global COVID Vaccine Market: Attractiveness Analysis by Regional

Chapter 3 Competitive Analysis

3.1 Global COVID Vaccine Market
3.1.1 Global COVID Vaccine Market Revenue (USD Billion), By Players 221
3.1.2 Global COVID Vaccine Market Revenue Share (%), By Players 2021

Chapter 5 Global COVID Vaccine Market: By Types

5.1 Global COVID Vaccine Market Share (%), By Types, 2021
5.2 Global COVID Vaccine Market Revenue (USD Billion), By Types, 2021 – 2028
5.3 Global COVID Vaccine Market Revenue (USD Billion), T1 ,2021-2028
5.4 Global COVID Vaccine Market Revenue (USD Billion), T2,2021-2028
5.5 Global COVID Vaccine Market Revenue (USD Billion), T3,2021-2028
5.6 Global COVID Vaccine Market Revenue Share (%), By Types, 2021 – 2028
5.7 Global COVID Vaccine Market Revenue Market Share (%), By Types, 2021-2028

Chapter 6 Global COVID Vaccine Market: By Application

6.1 Global COVID Vaccine Market Share (%), By Application, 2021
6.2 Global COVID Vaccine Market Revenue (USD Billion), By Application, 2021 – 2028
6.3 Global COVID Vaccine Market Revenue (USD Billion), A1, 2021-2028
6.4 Global COVID Vaccine Market Revenue (USD Billion), A2, 2021-2028
6.5 Global COVID Vaccine Market Revenue (USD Billion), A3, 2021-2028
6.6 Global COVID Vaccine Market Revenue Share (%), By Application, 2021 – 2028
6.7 Global COVID Vaccine Market Revenue Market Share (%), By Application, 2021-2028

Chapter 7 North America COVID Vaccine Market Analysis

7.1 North America Market Snapshot
7.1.1 North America COVID Vaccine Market Revenue and Growth Rate (%), 2021-2028.
7.1.2 North America COVID Vaccine Market Revenue (USD Billion) Overview, by Country, 2021 – 2028
7.1.3 North America COVID Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2021 – 2028.
7.1.4 North America COVID Vaccine Revenue (USD Billion) Overview, by Type, 2021-2028
7.1.5 North America COVID Vaccine Revenue (USD Billion) Overview, by Application , 2021-2029

Chapter 8 Europe COVID Vaccine Market Analysis

8.1 Europe Market Snapshot
8.1.1 Europe COVID Vaccine Market Revenue and Growth Rate (%), 2021-2028.
8.1.2 Europe COVID Vaccine Market Revenue (USD Billion) Overview, by Country, 2021 – 2029
8.1.3 Europe COVID Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2021 – 2028
8.1.4 Europe COVID Vaccine Revenue (USD Billion) Overview, by Type, 2021-2028
8.1.5 Europe COVID Vaccine Revenue (USD Billion) Overview, by Application, 2021-2028

Chapter 9 Asia Pacific COVID Vaccine Market Analysis

9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific COVID Vaccine Market Revenue and Growth Rate (%), 2021-2028.
9.1.2 Asia Pacific COVID Vaccine Market Revenue (USD Billion) Overview, by Country, 2021 – 2028
9.1.3 Asia Pacific COVID Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2021 – 2028.
9.1.4 Asia Pacific COVID Vaccine Revenue (USD Billion) Overview, by Type, 2021-2028
9.1.5 Asia Pacific COVID Vaccine Revenue (USD Billion) Overview, by Application, 2021-2028

Chapter 10 Latin America COVID Vaccine Market Analysis

10.1 Latin America Market Snapshot
10.1.1 Latin America COVID Vaccine Market Revenue and Growth Rate (%), 2021-2028
10.1.2 Latin America COVID Vaccine Market Revenue (USD Billion) Overview, by Country, 2021 – 2028
10.1.3 Latin America COVID Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2021 – 2028.
10.1.4 Latin America COVID Vaccine Revenue (USD Billion) Overview, by Type, 2021-2028
10.1.5 Latin America COVID Vaccine Revenue (USD Billion) Overview, by Application, 2021-2028

Chapter 11 Middle East & Africa COVID Vaccine Market Analysis

11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa COVID Vaccine Market Revenue and Growth Rate (%), 2021-2028.
11.1.2 Middle East & Africa COVID Vaccine Market Revenue (USD Billion) Overview, by Country, 2021 – 2028
11.1.3 Middle East & Africa COVID Vaccine Market Revenue (USD Billion) and Growth Rate (%), 2021 – 2028.
11.1.4 Middle East & Africa COVID Vaccine Revenue (USD Billion) Overview, by Type, 2021-2028
11.1.5 Middle East & Africa COVID Vaccine Revenue (USD Billion) Overview, by Application, 2021-2028

Chapter 12 Competitive Analysis

12.1 COMPANY 1.

12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 COMPANY 1. Total Company Revenue 2015-2020
12.1.3 COMPANY 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 COMPANY 1. Total Company Revenue, By Region 2015-2020
12.1.5 COMPANY 1. Global COVID Vaccine Product Category and Description
12.1.6 COMPANY 1. Recent Activity 2015-2020
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis

12.2 Company 2.
12.4 Company 4
12.5 Company 5
12.6 Company 6
12.7 Company 7

Chapter 13 Market Research Findings & Conclusion

Chapter 14 Research Methodology

14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report

COVID Vaccine Market Growth, Statistics Industry Outlook to 2028

Choose License

Single User: $2145

Single user license:

Allows report access to only one user
3 months of post-purchase analyst support

Multi User: $2845

Multi user license:

Allows report access to up to six users
6 months of post-purchase analyst support

Corporate User: $3245

Corporate user license:

Allows report access to unlimited users
12 months of post-purchase analyst support

Key Highlights & Report Features

Continuous Data Monitoring:
Real-time data tracking with continuous monitoring and updates from January 2015 to August 10, 2025
Global Market Intelligence:
Comprehensive market data available for 60+ countries with detailed regional analysis
Extensive Product Coverage:
Example shown is representative of similar data available for 20,000+ products across categories
Customization Options:
Tailored datasets available with detailed supplier, buyer quantity, and shipment information
Current Market Insights:
Pricing trends updated monthly, ensuring you always have the latest market intelligence
Comprehensive Analysis:
Reports include both qualitative and quantitative analysis, delivering actionable insights to support strategic decision-making
Comprehensive shipment-level details across all covered countries